Patrick G. Lepore - Nov 15, 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role: Director
Signature: /s/ Mutya Harsch, as attorney-in-fact for Patrick G. LePore
Stock symbol: VYNE
Transactions as of: Nov 15, 2023
Transactions value $: $50,778
Form type: 4
Date filed: 11/17/2023, 05:03 PM
Previous filing: Mar 22, 2023
Next filing: Dec 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VYNE	Common Stock	Purchase	$50.8K	+13K	+55.39%	$3.91	36.5K	Nov 15, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $3.57 to $4.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $3.57 to $4.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.